Tetrabenazine is a vesicular monoamine transporter 2 (VMAT2) inhibitor. It works by blocking the storage of neurotransmitters like dopamine, serotonin, and norepinephrine in nerve cells, reducing their levels in the brain. This helps decrease excessive dopamine activity, which is responsible for involuntary movements.
Tetrabenazine is primarily used to treat hyperkinetic movement disorders, such as Huntington’s disease, tardive dyskinesia, and chorea, by controlling abnormal, involuntary movements.